Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study

• Prif Awduron: Matti Kivikko, MD, PhD (Awdur), Mikko Kuoppamäki, MD, PhD (Awdur), Lauri Soinne, MD, PhD (Awdur), Stig Sundberg, PhD (Awdur), Pasi Pohjanjousi, MSc (Awdur), Juha Ellmen, PhD (Awdur), Risto O. Roine, MD, PhD (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Elsevier, 2015-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Background: Intravenous levosimendan is indicated for acute heart failure. The compound has shown promising beneficial effects in ischemic stroke models. Objective: We evaluated the efficacy and safety of oral levosimendan in patients with a history of cerebral ischemia. Methods: In a randomized, do...